C4BPA expression | P value | ||
---|---|---|---|
High (n=96) | Low (n=75) | ||
Age (y.o. mean ± SD) | 65.7±9.3 | 65.9±10.4 | 0.87 |
Gender (male/female) | 51/45 | 48/27 | 0.15 |
Tumor location (head/body-tail) | 67/30 | 56/19 | 0.50 |
Tumor volume (mm3 median (IQR)) | 6462 (4450,13124) | 6283 (4450,13124) | 0.18 |
UICC | |||
pT stage (pT3,4/pT1,2) | 95/1 | 72/3 | 0.20 |
pN stage (pN1,2,3/pN0) | 74/22 | 54/21 | 0.45 |
Curability (R1,2/R0) | 36/60 | 34/41 | 0.30 |
Perioperative therapy | |||
Neoadjuvant therapy (+/−) | 36/60 | 38/37 | 0.84 |
Adjuvant chemotherapy (+/−) | 85/11 | 61/14 | 0.19 |
Recurrence site | |||
Local recurrence (+/−) | 36/60 | 31/44 | 0.61 |
Hematogenous recurrence (+/−) | 49/47 | 48/27 | 0.088 |